Jersey sales for Cincinnati Bengals defensive tackle Devon Still in support of his 4-year-old daughter Leah, who has pediatric cancer, have exceeded $1 million.

More than 10,000 orders have come in from all 50 U.S. states as well as from Canada, the UK and Australia.

The proceeds are going to Cincinnati Children’s Hospital Medical Center. Sales from the $100 jerseys will benefit pediatric cancer research at the hospital.

The Bengals on Sunday finalized plans for the program. Jersey sales will continue through Oct. 20. The team put a link on Bengals.com for fans to contribute directly to Cincinnati Children’s. They will present a check to Cincinnati Children’s that will exceed $1 million at the Nov. 6 game vs. the Cleveland Browns at Paul Brown Stadium. They are absorbing the cost of the first 10,000 jerseys — approximately $500,000 — allowing the full sale price of the jerseys to go to Cincinnati Children’s.

On sales in excess of 10,000, Cincinnati Children’s will continue to benefit from all sales minus the cost of the jerseys.

“We applaud Devon for his openness in sharing his daughter’s challenging story nationwide through media and social media,” Bengals executive vice president Katie Blackburn said in a statement.

“We also applaud the response of our fans and many others to the jersey sales. The welfare of Devon and Leah are foremost in our minds, but we are proud and excited to be able to be a part of something that can help advance the cause of fighting childhood cancer.”

Michael Fisher, President of Cincinnati Children’s, said in a statement: “I want to thank Devon and his family for sharing their story. Not only has it generated international attention to the issue of pediatric cancer, but it has served as an inspiration to many other families that are traveling a similar path. I also want to thank Mike Brown, Katie Blackburn, and the entire Cincinnati Bengals organization for their incredibly generous and thoughtful approach to this important effort.

“Finally, I want to thank the many individual donors. We promise to be good stewards of every dollar in our ongoing effort to find new and better ways to treat pediatric cancers.”